Once-Daily (od) Fluticasone Furoate/vilanterol (ff/vi: 100/25mcg) Compared With Twice-Daily (bd) Fluticasone Propionate/salmeterol (fsc: 250/50mcg) In Patients With COPD

被引：0

作者：

Dransfield, M. T. ^{[1
]}

Crim, C. C. ^{[2
]}

Feldman, G. ^{[3
]}

Korenblat, P. E. ^{[4
]}

Laforce, C. ^{[5
]}

Locantore, N. ^{[2
]}

Pistolesi, M. ^{[6
]}

Watkins, M. ^{[2
]}

Martinez, F. J. ^{[7
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] GlaxoSmithKline, Reseach Triangle Pk, NC USA

[3] South Carolina Pharmaceut Res, Spartanburg, SC USA

[4] Clin Res Ctr LLC, St Louis, MO USA

[5] Carolina Allergy & Asthma, Cary, NC USA

[6] Univ Florence, Florence, Italy

[7] Univ Michigan, Ann Arbor, MI 48109 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A2432

引用

页数：1

共 50 条

[21] A Randomized Trial Of Once-Daily Fluticasone Furoate/vilanterol 100/25 Versus Vilanterol 25 To Evaluate The Contribution On Lung Function Of Fluticasone Furoate In The Combination In Subjects With COPD
Siler, T.
Nagai, A.
Scott-Wilson, C. A.
Midwinter, D. A.
Crim, C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[22] EFFICACY AND SAFETY OF ONCE-DAILY INDACATEROL/MOMETASONE COMPARED WITH TWICE-DAILY SALMETEROL/FLUTICASONE IN PATIENTS WITH MODERATE TO VERY SEVERE COPD
Kirsten, Anne-Maria
Richard, Alexia
Tanase, Ana-Maria
Cao Weihua
Hosoe, Motoi
Hederer, Bettina
THORAX, 2014, 69 : A187 - A187
[23] Cost-Effectiveness of Fluticasone Propionate/Salmeterol (250/50mcg) Compared to Salmeterol (50mcg) in Patients with Chronic Obstructive Pulmonary Disease: Economic Evaluation of Study SCO100250
Dalal, A. A.
Blanchette, C. M.
Petersen, H.
St Charles, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[24] Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 μG Versus Twice-Daily Fluticasone Propionate 250 μG in Adolescents and Adults with Persistent Asthma
Tomlinson, Ryan
Parks, Daniel
Martin, Alan
LUNG, 2017, 195 (05) : 571 - 574
[25] Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 µG Versus Twice-Daily Fluticasone Propionate 250 µG in Adolescents and Adults with Persistent Asthma
Ryan Tomlinson
Daniel Parks
Alan Martin
Lung, 2017, 195 : 571 - 574
[26] ASTHMA-RELATED EXACERBATIONS AND SABA USE ASSOCIATED WITH ONCE-DAILY FLUTICASONE FUROATE/VILANTEROL COMPARED TO TWICE-DAILY BUDESONIDE/FORMOTEROL
Averell, C.
Germain, G.
Laliberte, F.
Duh, M.
Lima, R.
Slade, D.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S33 - S33
[27] Clinical markers of worsening asthma with the fluticasone propionate/salmeterol 100/50 Diskus® (FSC) vs fluticasone propionate (FP) 250mcg alone in patients requiring FP 250 mcg BID for asthma stability
Dorinsky, PM
Yancey, SW
Waiticus-Edwards, K
Edwards, L
CHEST, 2003, 124 (04) : 88S - 88S
[28] Efficacy And Safety Of Once-Daily Fluticasone Furoate/vilanterol (ff/vi) And Ff Over 12 Weeks In Patients With Persistent Asthma
Bernstein, D. I.
Bateman, E. D.
Woodcock, A.
Toler, W. T.
Forth, R.
Jacques, L.
Nunn, C.
O'Byrne, P. M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[29] COPD-Related Outcomes And Costs For Patients On Combination Fluticasone Propionate/Salmeterol 250/50mcg Versus Anticholinergics In A Comorbid COPD/Depression Population
Dalal, A. A.
Shah, M.
D'Souza, A. O.
Chaudhari, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[30] LONG-TERM EFFECTS OF ONCE-DAILY MOMETASONE FUROATE, TWICE-DAILY FLUTICASONE PROPIONATE, AND ONCE-DAILY MONTELUKAST ON BONE MINERAL DENSITY IN PATIENTS WITH MILD ASTHMA
Maspero, J.
Backer, V.
Yao, R.
Teper, A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A41 - A41

← 1 2 3 4 5 →